# Eirini Zacharopoulou

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/eirini-zacharopoulou/

## Facts

| Field | Value |
| --- | --- |
| Citations | 388 |
| Field | Inflammatory Bowel Disease |
| h-index | 11 |
| i10-index | 12 |
| Last Known Institution | General Hospital of Nikea |
| OpenAlex ID | https://openalex.org/A5015247955 |
| ORCID iD | 0000-0001-8154-0444 |
| Works | 64 |

## Researcher papers

- [The contribution of long non-coding RNAs in Inflammatory Bowel Diseases](https://scholariq.org/papers/the-contribution-of-long-non-coding-rnas-in-inflammatory-bowel-diseases/)
- [Early Intervention in Ulcerative Colitis: Ready for Prime Time?](https://scholariq.org/papers/early-intervention-in-ulcerative-colitis-ready-for-prime-time/)
- [TL1A: A New Potential Target in the Treatment of Inflammatory Bowel Disease](https://scholariq.org/papers/tl1a-a-new-potential-target-in-the-treatment-of-inflammatory-bowel-disease/)
- [Patients with Inflammatory Bowel Disease Are Not at Increased Risk of COVID-19: A Large Multinational Cohort Study](https://scholariq.org/papers/patients-with-inflammatory-bowel-disease-are-not-at-increased-risk-of-covid-19-a/)
- [Treat to target or ‘treat to clear’ in inflammatory bowel diseases: one step further?](https://scholariq.org/papers/treat-to-target-or-treat-to-clear-in-inflammatory-bowel-diseases-one-step/)
- [Targeting the gut layers in Crohn’s disease: mucosal or transmural healing?](https://scholariq.org/papers/targeting-the-gut-layers-in-crohn-s-disease-mucosal-or-transmural-healing/)
- [Predictors of Response to Vedolizumab in Patients with Ulcerative Colitis: Results from the Greek VEDO-IBD Cohort](https://scholariq.org/papers/predictors-of-response-to-vedolizumab-in-patients-with-ulcerative-colitis/)
- [Genetic analysis and clinical description of Greek patients with Peutz-Jeghers syndrome: Creation of a National Registry](https://scholariq.org/papers/genetic-analysis-and-clinical-description-of-greek-patients-with-peutz-jeghers/)
- [Response to Anti-α4β7 Blockade in Patients With Ulcerative Colitis Is Associated With Distinct Mucosal Gene Expression Profiles at Baseline](https://scholariq.org/papers/response-to-anti-4-7-blockade-in-patients-with-ulcerative-colitis-is-associated/)
- [Comparison between tofacitinib and ustekinumab as a third‐line therapy in refractory ulcerative colitis: A multicenter international study](https://scholariq.org/papers/comparison-between-tofacitinib-and-ustekinumab-as-a-third-line-therapy-in/)
- [Effectiveness and Safety of Teduglutide Treatment in Adult Patients with Short Bowel Syndrome: A Case Series and Review of Current Evidence](https://scholariq.org/papers/effectiveness-and-safety-of-teduglutide-treatment-in-adult-patients-with-short/)

## Researcher topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)
- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)

## Researcher university

- [General Hospital of Nikea](https://scholariq.org/institutions/general-hospital-of-nikea/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.